Redirecting gene-modified T cells toward various cancer types using tagged antibodies K Tamada, D Geng, Y Sakoda, N Bansal, R Srivastava, Z Li, E Davila Clinical Cancer Research 18 (23), 6436-6445, 2012 | 289 | 2012 |
Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity D Choubey, X Duan, E Dickerson, L Ponomareva, R Panchanathan, ... Journal of Interferon & Cytokine Research 30 (6), 371-380, 2010 | 128 | 2010 |
Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4 R Srivastava, D Geng, Y Liu, L Zheng, Z Li, MA Joseph, C McKenna, ... Cancer research 72 (23), 6209-6216, 2012 | 94 | 2012 |
When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function D Geng, L Zheng, R Srivastava, N Asprodites, C Velasco-Gonzalez, ... Blood, The Journal of the American Society of Hematology 116 (18), 3494-3504, 2010 | 92 | 2010 |
Chemistry and pharmacology of Centella asiatica: a review R Srivastava, YN Shukla, S Kumar J Med Arom Plant Sci 19, 1049-56, 1997 | 88 | 1997 |
Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E R Srivastava, R Aggarwal, MR Bhagat, A Chowdhury, S Naik Journal of viral hepatitis 15 (12), 910-916, 2008 | 84 | 2008 |
Biochemical and structural characterization of a novel halotolerant cellulase from soil metagenome R Garg, R Srivastava, V Brahma, L Verma, S Karthikeyan, G Sahni Scientific reports 6 (1), 39634, 2016 | 79 | 2016 |
Selective IRAK4 inhibition attenuates disease in murine lupus models and demonstrates steroid sparing activity S Dudhgaonkar, S Ranade, J Nagar, S Subramani, DS Prasad, ... The Journal of Immunology 198 (3), 1308-1319, 2017 | 68 | 2017 |
ChaC2, an enzyme for slow turnover of cytosolic glutathione A Kaur, R Gautam, R Srivastava, A Chandel, A Kumar, S Karthikeyan, ... Journal of Biological Chemistry 292 (2), 638-651, 2017 | 66 | 2017 |
Adaptive immune responses during acute uncomplicated and fulminant hepatitis E R Srivastava, R Aggarwal, S Sachdeva, MI Alam, S Jameel, S Naik Journal of gastroenterology and hepatology 26 (2), 306-311, 2011 | 65 | 2011 |
Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens D Geng, L Zheng, R Srivastava, C Velasco-Gonzalez, A Riker, ... Cancer research 70 (19), 7442-7454, 2010 | 57 | 2010 |
Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease J Nagar, S Ranade, V Kamath, S Singh, P Karunanithi, S Subramani, ... International immunopharmacology 21 (2), 328-335, 2014 | 29 | 2014 |
DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients H Vasiyani, M Mane, K Rana, A Shinde, M Roy, J Singh, D Gohel, ... Apoptosis 27 (11), 961-978, 2022 | 27 | 2022 |
Discovery of potent and orally bioavailable small molecule antagonists of Toll-like receptors 7/8/9 (TLR7/8/9) CP Mussari, DS Dodd, RK Sreekantha, L Pasunoori, H Wan, SL Posy, ... ACS Medicinal Chemistry Letters 11 (9), 1751-1758, 2020 | 26 | 2020 |
Cross-talk between 4-1BB and TLR1–TLR2 Signaling in CD8+ T Cells Regulates TLR2′s Costimulatory Effects AM Joseph, R Srivastava, J Zabaleta, E Davila Cancer immunology research 4 (8), 708-716, 2016 | 16 | 2016 |
Antifeedant compounds from Centella asiatica. R Srivastava, YN Shukla, AK Tripathi | 15 | 1997 |
Antibacterial activity of Centella asiatica. R Srivastava, YN Shukla, MP Darokar | 15 | 1997 |
Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area MM Husain, R Srivastava, R Akondy, R Aggarwal, S Jameel, S Naik Intervirology 54 (3), 139-143, 2011 | 13 | 2011 |
Factors influencing organisational effectiveness in the educational sector S Pandya, RK Srivastava European Journal of Education Studies, 2017 | 12 | 2017 |
Some chemical constituents from Centella asiatica R Srivastava, YN Shukla Indian Drugs 33 (5), 233-234, 1996 | 12 | 1996 |